1,2,3,4-Tetrahydro-1,4-epiminonaphthalene hydrochloride, 95%, 100mg

(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(2-(hydroxymethyl)phenoxy)tetrahydro-2H-pyran-3,4,5-triol, 95.0%, 25g

4',4''',4''''',4'''''''-(ethene-1,1,2,2-tetrayl)tetrakis(([1,1'-biphenyl]-4-amine)), 98%, 5g

N-BOC-3,4-DIHYDRO-2(1H)-QUINOLINONE, 95.0%, 1g

2,6-Difluoro-4-methoxybenzene-1-sulfonamide, 97%, 250mg

N-[2-(Cyclohexyloxy)-4-nitrophenyl]methanesulfonamide, 98%, 250mg

(E)-2-(2-NITROVINYL)THIAZOLE, 95.0%, 250mg

4-(4-bromophenyl)-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-6-carboxylic acid, 95.0%, 1g

[1-(2-furyl)-3-buten-1-yl](2-thienylmethyl)amine hydrochloride, 95.0%, 1g

ETHYL 3-(2,4,5-TRIFLUORO-3-METHYLPHENYL)-3-OXOPROPANOATE, 95.0%, 250mg

(Cyclohexyl-CAAC)Rh(COD)Cl>98.0%(T)100mg

6-CHLORO-8-HYDROXYQUINOLINE, 95.0%, 2g

Indice de réfraction standard BRIX, 0 % de saccharose stabilisé, 1,33299 (20 °C)